AlloFuse Micro Fibers are the latest addition to the AlloFuse line of Fibers and Fiber Boat products, expanding the company's portfolio.

Influx Fibrant cortical allograft constructs are available in Anchor, Boat, Bullet, Pak and Wrap formats.

FDA granted Breakthrough Medical Device designation for the use of OsteoAdapt SP in Anterior Lumbar Interbody Fusion.

The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the original $315 million.

Based on blood clotting processing, this new macroporous calcium phosphate cement is designed to stimulate bone regeneration.

The synthetic bone graft was launched in the U.S. in 2021, and has since been adopted by surgeons for use in spinal fusion surgeries.

Lipogems will conduct an IDE study for treatment of knee osteoarthritis compared to corticosteroids for a period of 12 months.

Maxx-BMC's Lead Screw technology helps pinpoint precise areas of the growth factor layer of bone marrow aspirate in a matter of seconds.

Kuros Biosciences announces favorable preliminary results for MagnetOs as standalone alternative to autograft in its first randomized controlled trial.

FDA granted market authorization for the antibiotic eluting product CERAMENT G, for the indication bone infection (osteomyelitis).